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INVITED COMMENTARYCommentary on ‘ABO Blood Type does not Inﬂuence the Risk of
Cardiovascular Complications and Mortality After Vascular Surgery’
H.H. Dosluoglu a,*, N.D. Nader b
a Department of Surgery, Division of Vascular Surgery, VA Western NY Healthcare System, 3495 Bailey Ave, Buffalo, NY 14215, USA
b Department of Anesthesiology, State University of New York at Buffalo, Buffalo, NY, USADuring the past four decades, ABO blood types has been
proposed as one of the prognostication factors of cardio-
vascular disease and non-O blood groups have been identi-
ﬁed as a risk factor for coronary artery disease and
associated mortality.1,2 A similar trend has been described
for development of cardiovascular complications in the
postoperative period. These interesting observations have
been attributed to elevated levels of vonWillebrand factor in
individuals with non-O blood groups,3 which plays a critical
role in subendothelial adhesion of platelets, a process that is
considered an initial step in acute clot formation and
atherogenesis, especially under high shear stress conditions.
In this issue of European Journal of Vascular and Endo-
vascular Surgery, Bakker and colleagues present a retrospec-
tive review of 4679 patients undergoing vascular surgery
from 1990 through 2011.4 Cardiac complications occurred in
4.9% of non-O blood type and 5.5% of O blood group patients
(P ¼ 0.42) within 30 days after surgery, and there was no
signiﬁcant difference in mortality during a median follow up
of 4 years. In multivariate analysis, blood type was not
identiﬁed as an independent predictor of cardiac complica-
tion after major vascular surgery. This is basically a negative
study, however the absence of evidencemay not be the same
as evidence of absence due to some limitations of this study,
including its retrospective nature, relatively small number of
patients with short follow up compared to previous studies
with 24e26 year follow up,2 and not including all perioper-
ative and late thrombotic events (venous thromboembolic,
graft occlusion, limb ischemia) in their analysis.
While the results of this study conﬂict in part with previous
observations, the authors observed signiﬁcantly higher prev-
alence of ischemic heart disease (p¼ 0.02) in the non-O group
at baselinewhereas therewere strong trends in the prevalence
of cerebrovascular disease (p ¼ 0.08) and hypertension
(p¼ 0.06) in the O group. Multivariate regression analysis was
performed adjusting for several demographic variables, as well
as ischemic heart disease. Although this is an accepted statis-
tical method to examine the blood type as an independent
contributing factor, it eliminates the interaction between the
blood type and the prevalence of the ischemic heart disease.DOI of original article: http://dx.doi.org/10.1016/j.ejvs.2012.11.022
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http://dx.doi.org/10.1016/j.ejvs.2012.12.017It is quite possible that the previously reported increase in
postoperative cardiac complications associated with non-O
blood type is simply due to a higher incidence of ischemic
heart disease in this population. In a recent epidemiologic
metaanalysis by Harvard School of Public Health including
62,073 women from the Nurses’ Health Study (NHS) and
27,428 men from the Health Professionals Follow-up Study
(HPFS),2 the investigators found that, when compared with
individuals with type O, those with type A blood have a 6%
greater risk of heart disease, those with type B have a 15%
greater risk, and those with type AB have a 23% greater risk.
However, just over 6% of the coronary heart disease cases
were attributable to the A, B, or AB blood types. It is important
to note that population with A blood group have higher levels
of total and LDL cholesterol which may contribute to athero-
genesis, a common denominator of coronary heart disease
and peripheral arterial disease. No such analysis was done for
patients in the study by Bakker et al.4
The clinical signiﬁcance of this epidemiologic observation
is highly questionable,5 and the study by Bakker et al.4 adds
to the previous work questioning the clinical signiﬁcance of
blood types on postoperative thrombotic complications and
long term mortality.6 As for patients who ask their physi-
cians about blood type concerns, Daniel Levy, MD, director
of the Framingham Heart Study, medical ofﬁcer of the
National Heart, Lung, and Blood Institute, and professor of
medicine at Boston University School of Medicine offered
this response: “Your blood type will be most important on
the day you need a transfusion.”5
Although the clinical signiﬁcance of the association
between the ABO blood type and ischemic heart disease is
questionable, the risk of ischemic heart disease at baseline
seems to be higher in patients with non-O blood groups. Being
attentive to this higher risk and appropriate risk adjustment
with aggressive lifestylemodiﬁcation, lipid control, antiplatelet
and statin use in these patients with peripheral arterial disease
will be crucial in decreasing perioperative and long term
cardiovascular morbidity andmortality.Whether patients with
non-O blood type groups need more aggressive risk adjust-
ment still remains to be seen.REFERENCES
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